Synapse - Peter Maslak

Results (197)

Discovery and validation of a novel class of small molecule inhibitors of the Cdc7 kinase: Modulation of tumor cell growth in vitro and in vivo

Meeting Abstract

Frattini, M. G.; Shum, D.; O'dwyer, K. M.; Brentjens, R. J.; Yeh, R.; Maslak, P. G.; Djaballah, H.; Kelly, T. J.
Cancer Research (2009)

Fulltext@MSK | Save

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses

Journal Article

Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms

Meeting Abstract

Brown, A. B.; Krug, L. M.; Maslak, P.; James, L. P.; Dao, T.; Tyson, L.; Chanel, S. M.; Bekele, S.; Scheinberg, D. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)

Meeting Abstract

Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
Blood (2008)

Fulltext@MSK | Save

Small molecule inhibition of Cdc7, a key cell cycle regulator and novel therapeutic target, successfully inhibits leukemia cell growth in vitro and in vivo

Meeting Abstract

Frattini, M. G.; Shum, D.; O'dwyer, K. M.; Brentjens, R. J.; Yeh, R.; Maslak, P.; Heaney, M. L.; Jurcic, J.; Djaballah, H.; Kelly, T. J.
Blood (2008)

Fulltext@MSK | Save

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

Journal Article

Zhou, P.; Comenzo, R. L.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Maslak, P. G.; Fleisher, M.; Hoffman, J.; Jhanwar, S.; Young, J. W.; more...
Blood (2008)

Fulltext@MSK | Save

Azacitidine and the beginnings of therapeutic epigenetic modulation

Journal Article

O'dwyer, K.; Maslak, P.
Expert Opinion on Pharmacotherapy (2008)

Fulltext@MSK | Save

Acute myeloid leukemia

Journal Article

O'Donnell, M. R.; Appelbaum, F. R.; Coutre, S. E.; Damon, L. E.; Erba, H. P.; Foran, J.; Lancet, J.; Maness, L. J.; Marcucci, G.; Maslak, P. G.; more...
Journal of the National Comprehensive Cancer Network (2008)

Fulltext@MSK | Save

A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease

Journal Article

Maslak, P. G.; Dao, T.; Gomez, M.; Chanel, S.; Packin, J.; Korontsvit, T.; Zakhaleva, V.; Pinilla-Ibarz, J.; Berman, E.; Scheinberg, D. A.
Leukemia (2008)

Fulltext@MSK | Save

Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes

Journal Article

Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
Clinical Cancer Research (2008)

Fulltext@MSK | Save